Title |
Acceptability of Antiretroviral Pre-exposure Prophylaxis from a Cohort of Sexually Experienced Young Transgender Women in Two U.S. Cities
|
---|---|
Published in |
AIDS and Behavior, April 2018
|
DOI | 10.1007/s10461-018-2127-0 |
Pubmed ID | |
Authors |
Arjee J. Restar, Lisa Kuhns, Sari L. Reisner, Adedotun Ogunbajo, Robert Garofalo, Matthew J. Mimiaga |
Abstract |
Emtricitabine/tenofovir disoproxil fumarate as pre-exposure prophylaxis (PrEP) can prevent HIV infection among at-risk individuals, including young transgender women (YTW). We used baseline data from 230 HIV-uninfected YTW (ages 16-29 years) who were enrolled in Project LifeSkills during 2012-2015. We examined factors associated with perceived acceptability of PrEP use (mean score = 23.4, range 10.0-30.0). Participants were largely transgender women of color (67%) and had a mean age of 23 years (SD = 3.5). In an adjusted multiple linear regression model, PrEP interest (β = 3.7, 95% CI 2.2-5.2) and having a medical provider who meets their health needs (β = 2.9, 95% CI 1.3-4.4) was associated with higher PrEP acceptability scores, whereas younger age (21-25 vs 26-29 years) (β = -2.0, 95% CI - 3.6 to - 0.4) and reporting transactional sex in the past 4 months (β = - 1.5, 95% CI - 3.0 to - 0.1) was associated with lower PrEP acceptability scores (all p values < 0.05). Enhancing PrEP-related interventions by addressing the unique barriers to uptake among YTW of younger age or those with history of transactional sex could bolster PrEP acceptability for this population. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 67% |
Unknown | 2 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 50% |
Scientists | 2 | 33% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 104 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 14% |
Student > Master | 13 | 13% |
Student > Bachelor | 13 | 13% |
Student > Postgraduate | 9 | 9% |
Student > Ph. D. Student | 8 | 8% |
Other | 17 | 16% |
Unknown | 29 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 18% |
Psychology | 13 | 13% |
Social Sciences | 12 | 12% |
Nursing and Health Professions | 9 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Other | 11 | 11% |
Unknown | 37 | 36% |